TaiGen Biopharmaceuticals Holdings Limited (4157)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
9. 02
+0.32
+3.6782%
NT$
7.18B Market Cap
- P/E Ratio
- Div Yield
1.61M Volume
- Eps
NT$ 8.7
Previous Close Want to track 4157 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TaiGen Biopharmaceuticals Holdings Limited (4157) Statistics
Valuation metrics
Market Cap 7.18B
Enterprise value 6.13B
Trailing P/E (ttm) 109.76
Forward P/E -
PEG ratio -0.12
Price/Sales (ttm) 24.11
Price/Book (mrq) 5.96
Enterprise Value/Revenue 23.69
Enterprise Value/EBITDA 198.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 896.99K
Average volume (90 days) 1.13M
Price summary
52-Week low 7.73
52-Week high 16.4
Beta -
50-Day moving average 8.58
200-Day moving average 10.26
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.29%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 19.34%
Book value per share (mrq) 1.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
